FDA Checking On Alleged Arrival Of Moderna Vaccine In PH

FDA Moderna

The FDA was checking on the alleged arrival of the Moderna vaccine in the Philippines. The Food and Drug Administration (FDA) on Friday said that the agency was checking on reports that the Moderna COVID-19 vaccine had allegedly arrived in the Philippines. This, as the agency disclosed that Moderna may apply for an emergency use … Read more

FDA Warns Against Counterfeit Moderna COVID-19 Vaccine In PH

Moderna FDA

The FDA warned the public against counterfeit Moderna COVID-19 vaccine in the Philippines The Food and Drug Administration (FDA) on Friday warned the public against counterfeit or fake Moderna COVID-19 vaccine as there’s no available supply yet in the Philippines. In an online interview, FDA Director-General Eric Domingo reiterated that Moderna may apply for an … Read more

Moderna COVID-19 Vaccine Confers At Least 3 Months Immunity — Study

Moderna vaccine

Moderna COVID-19 vaccine conferred at least 3 months of immunity — study. A study showed Thursday that Moderna COVID-19 vaccine, which the company said was recently demonstrated to have 94% efficacy, caused the human immune system to produce potent antibodies that could endure for at least three months. Researchers at NIAID (National Institute for Allergies … Read more

Moderna Plans To Start Testing Its COVID-19 Vaccine In Children

Moderna vaccine

Moderna had planned to start testing its COVID-19 vaccine in children. Moderna on Wednesday announced that the company had planned to start testing its coronavirus vaccine in children ages 12 to 17. In a report on ABS-CBN News, the said study — listed Wednesday on clinicaltrials.gov — was to include 3,000 children wherein half will … Read more

Moderna COVID-19 Vaccine ‘94.5% Effective’ In Preventing Coronavirus Disease

Moderna vaccine

Moderna COVID-19 vaccine was “94.5% effective” in preventing coronavirus disease. Moderna Inc. on Monday said that the experimental COVID-19 vaccine was “94.5% effective” in preventing the coronavirus disease based on interim data from a late-stage trial. This, as the company became the second drugmaker in the United States to report results that far exceeded expectations … Read more